Real-world pharmacovigilance study of myelotoxicity with PARP inhibitors in breast and ovarian malignancies.

Authors: Jayalekshmi Jayakumar, Nikhil Vojjala, Chalothorn Wannaphut, Tijin Mathew, Charmi Bhanushali, Safa Saadat Afridi, Avi Ravi Harisingani, Deevyashali Parekh, Srinishant Rajarajan, Kalaivani Babu, Sripada Preetham Kasire, Rishab R. Prabhu, Arya Mariam Roy

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e23299

Source: Full article

---

Abstract

e23299